[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340859-105":59,"doc-detail-340859-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","loss-of-trop2-and-epithelial-cell-adhesion-molecule-expression-is-linked-to-grade-progression-in-pta-but-unrelated-to-disease-outcome-in-pt2-4-urothelial-bladder-carcinomas","Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas","","Trophoblast cell surface antigen 2 (TROP2; EpCAM2) and epithelial cell adhesion molecule (EpCAM; EpCAM1) have overlapping roles in epithelial development, yet their comparative behavior in bladder carcinoma remains unclear. This study used multiplex fluorescence immunohistochemistry with a deep-learning cell detection algorithm on over 2,700 urothelial bladder cancers in a tissue microarray to quantify expression patterns. TROP2 and EpCAM were highly interrelated, with coordinated loss associated with higher grade in pTa, while expression was not linked to outcome in pT2-4 tumors.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/loss-of-trop2-and-epithelial-cell-adhesion-molecule-expression-is-linked-to-grade-progression-in-pta-but-unrelated-to-disease-outcome-in-pt2-4-urothelial-bladder-carcinomas/340859/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/loss-of-trop2-and-epithelial-cell-adhesion-molecule-expression-is-linked-to-grade-progression-in-pta-but-unrelated-to-disease-outcome-in-pt2-4-urothelial-bladder-carcinomas/340859.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the study address about TROP2 and EpCAM in bladder cancer?","Question",{"text":112,"@type":113},"The study evaluates whether subtle differences and clinical relevance of TROP2 and EpCAM expression can be detected in urothelial bladder cancer, and whether they relate to progression or outcomes across tumor stages.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were TROP2 and EpCAM expression levels measured?",{"text":117,"@type":113},"TROP2 and EpCAM were assessed by multiplex fluorescence immunohistochemistry combined with a deep-learning based algorithm for automated cell detection on more than 2,700 cases in a tissue microarray format.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the main findings regarding expression and grade progression?",{"text":121,"@type":113},"TROP2 and EpCAM staining patterns were highly similar, with decreasing intensity as pTa grade increased. In pT2-4 carcinomas, expression was intermediate and significantly lower than pTa G2 low grade, but also not associated with pT, grade, UICC category, or survival.",{"name":123,"@type":110,"acceptedAnswer":124},"Does TROP2/EpCAM expression predict disease outcome in pT2-4 tumors?",{"text":125,"@type":113},"No. Within pT2-4 carcinomas, TROP2 and EpCAM staining levels, and the TROP2/EpCAM ratio, were unrelated to malignant phenotype and patient prognosis.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},340859,1790461997,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","TYPE Original Research PUBLISHED 12 January 2024 DOI 10.3389/fonc.2023.1342367  \nOPEN ACCESS  \nEDITED BY  \nFrancesca Sanguedolce, University of Foggia, Italy  \nREVIEWED BY Ming Yi,  \nZhejiang University, China Siyuan Cheng,  \nLouisiana State University Health Shreveport, United States  \n*CORRESPONDENCE Elena Bady  \n [e.bady@uke.de](e.bady@uke.de)  \nRECEIVED 21 November 2023  \nACCEPTED 21 December 2023  \nPUBLISHED 12 January 2024  \nCITATION  \nMüller JH, Plage H, Elezkurtaj S, Mandelkow T, Huang Z, Lurati MCJ, Raedler JB, Debatin NF, Vettorazzi E, Samtleben H, Hofbauer S, Furlano K, Neymeyer J, Goranova I, Ralla B, Weinberger S, Horst D, Roßner F, Schallenberg S, Marx AH, Fisch M, Rink M, Slojewski M, Kaczmarek K, Ecke T, Hallmann S, Koch S, Adamini N, Lennartz M, Minner S, Simon R, Sauter G, Zecha H,  \nSchlomm T and Bady E (2024) Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas.  \nFront. Oncol. 13:1342367 .  \ndoi: 10.3389/fonc.2023.1342367  \nCOPYRIGHT  \n© 2024 Müller, Plage, Elezkurtaj, Mandelkow, Huang, Lurati, Raedler, Debatin, Vettorazzi, Samtleben, Hofbauer, Furlano, Neymeyer, Goranova, Ralla, Weinberger, Horst, Roßner, Schallenberg, Marx, Fisch, Rink, Slojewski, Kaczmarek, Ecke, Hallmann, Koch, Adamini, Lennartz, Minner, Simon, Sauter, Zecha, Schlomm and Bady. This is an open-access article distributed under the terms of the  \nCreative Commons Attribution License (CC BY) .  \nThe use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nLoss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas  \nJan H. Müller 1, Henning Plage 2, Sefer Elezkurtaj 2, Tim Mandelkow 1, Zhihao Huang 1, Magalie C. J. Lurati 1, Jonas B. Raedler 1,3, Nicolaus F. Debatin 1, Eik Vettorazzi 4, Henrik Samtleben 5, Sebastian Hofbauer 2, Kira Furlano 2, Jörg Neymeyer 2, Irena Goranova 2, Bernhard Ralla 2, Sarah Weinberger 2, David Horst 6, Florian Roßner 6, Simon Schallenberg6, Andreas H. Marx 7, Margit Fisch 8, Michael Rink 8, Marcin Slojewski 9, Krystian Kaczmarek 9, Thorsten Ecke 10, Steffen Hallmann 10, Stefan Koch 11, Nico Adamini 12, Maximilian Lennartz 1, Sarah Minner 1, Ronald Simon 1, Guido Sauter 1, Henrik Zecha 12, Thorsten Schlomm 2 and Elena Bady 1*  \n1 Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany,  \n2 Department of Urology, Charite´ Berlin, Berlin, Germany, 3College of Arts and Sciences, Boston University, Boston, MA, United States, 4 Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 5 Department of Urology, Academic Hospital Fuerth, Fuerth, Germany, 6 Insitute of Pathology, Charite´ Berlin, Berlin, Germany, 7 Department of Pathology, Academic Hospital Fuerth, Fuerth, Germany, 8 Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany, 9 Department of Urology, University Hospital Stettin, Stettin, Poland, 10 Department of Urology, Helios Hospital Bad Saarow, Bad  \nSaarow, Germany, 11 Department of Pathology, Helios Hospital Bad Saarow, Bad Saarow, Germany, 12 Department of Urology, Albertinen Hospital, Hamburg, Germany  \nIntroduction: Trophoblast cell surface antigen 2 (TROP2; EpCAM2) is atransmembrane glycoprotein which is closely related to EpCAM (EpCAM; EpCAM1) . Both proteins share partial overlapping functions in epithelial development and EpCAM expression but have not been comparatively analyzed together in bladder carcinomas. TROP2 constitutes the target for the antibodydrug conjugate Sacituzumab go","cbCaibcblBmbIKLD","https://ap.wps.com/l/cbCaibcblBmbIKLD","pdf",6864877,"English","# Introduction\n# Methods\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What question does the study address about TROP2 and EpCAM in bladder cancer?\",\"answer\":\"The study evaluates whether subtle differences and clinical relevance of TROP2 and EpCAM expression can be detected in urothelial bladder cancer, and whether they relate to progression or outcomes across tumor stages.\"},{\"question\":\"How were TROP2 and EpCAM expression levels measured?\",\"answer\":\"TROP2 and EpCAM were assessed by multiplex fluorescence immunohistochemistry combined with a deep-learning based algorithm for automated cell detection on more than 2,700 cases in a tissue microarray format.\"},{\"question\":\"What were the main findings regarding expression and grade progression?\",\"answer\":\"TROP2 and EpCAM staining patterns were highly similar, with decreasing intensity as pTa grade increased. In pT2-4 carcinomas, expression was intermediate and significantly lower than pTa G2 low grade, but also not associated with pT, grade, UICC category, or survival.\"},{\"question\":\"Does TROP2/EpCAM expression predict disease outcome in pT2-4 tumors?\",\"answer\":\"No. Within pT2-4 carcinomas, TROP2 and EpCAM staining levels, and the TROP2/EpCAM ratio, were unrelated to malignant phenotype and patient prognosis.\"}]","Loss of TROP2 and epithelial cell adhesion molecule expression is linked to grade progression in pTa but unrelated to disease outcome in pT2-4 urothelial bladder carcinomas | PDF",1790039213,25,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61b6d6362a298c751183f9c29f6be48f.webp",983,1389,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/68766e4feda1a941572da02956b2aa96.webp",982,1388,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ce919dc580a2251b14a3f08b1cccf66.webp",981,1386,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/454dd531e727d65f0a273aeccf13a72c.webp",980,1385]